| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 36, 283-289, Copyright © 1990 by American Association for Clinical Chemistry
RA Wild, D Applebaum-Bowden, LM Demers, M Bartholomew, JR Landis, WR Hazzard and RJ Santen
Department of Obstetrics & Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City.
Concentrations of triglycerides are increased and concentrations of high-density lipoprotein (HDL) cholesterol are low in women with hyperandrogenism. These alterations could be related to excessive androgen or estrogen, to hyperinsulinism, or to a combination of these abnormalities. We examined their independent influences on lipids in 21 women with hyperandrogenism, subgrouped according to apparent source of androgen excess. Results for lipid, androgen, and insulin did not differ among subgroups, so these data were pooled. Free plus albumin- bound testosterone (uT) was correlated with triglycerides (r = 0.69, P less than 0.01) and HDL cholesterol (r = -0.56, P less than 0.01). Both triglycerides (r = 0.66, P less than 0.01) and HDL cholesterol (r = - 0.48, P less than 0.05) were also correlated with insulin measured during fasting. Partial correlation revealed that, after adjusting for insulin, lipids were associated with uT. This suggests that androgen excess is independently related to lipid excess. Insulin also was correlated with lipids when adjusted for uT. Free plus albumin-bound estradiol was not associated with any of the lipids. We conclude that altered lipids in women with hyperandrogenism result from the independent effects of androgen and insulin.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  B. Banaszewska, L. Pawelczyk, R. Z. Spaczynski, J. Dziura, and A. J. Duleba Effects of Simvastatin and Oral Contraceptive Agent on Polycystic Ovary Syndrome: Prospective, Randomized, Crossover Trial J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 456 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mudali, A. S. Dobs, J. Ding, J. A. Cauley, M. Szklo, and S. H. Golden Endogenous Postmenopausal Hormones and Serum Lipids: The Atherosclerosis Risk in Communities Study J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1202 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Knochenhauer, T. J. Key, M. Kahsar-Miller, W. Waggoner, L. R. Boots, and R. Azziz Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3078 - 3082. [Abstract] [Full Text]
|
|
|
|
|
|
E. Diamanti-Kandarakis, A. Mitrakou, S. Raptis, G. Tolis, and A. J. Duleba The Effect of a Pure Antiandrogen Receptor Blocker, Flutamide, on the Lipid Profile in the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2699 - 2705. [Abstract] [Full Text]
|
|
|
|
|
|
M. Rajkhowa, R. H. Neary, P. Kumpatla, F. L. Game, P. W. Jones, M. S. Obhrai, and R. N. Clayton Altered Composition of High Density Lipoproteins in Women with the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3389 - 3394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Luo, C. Labrie, A. Belanger, and F. Labrie Effect of Dehydroepiandrosterone on Bone Mass, Serum Lipids, and Dimethylbenz(a)anthracene-Induced Mammary Carcinoma in the Rat Endocrinology, August 1, 1997; 138(8): 3387 - 3394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Diamanti-Kandarakis, G. Tolis, and A. J. Duleba Androgens and Therapeutic Aspects of Antiandrogens in Women Reproductive Sciences, July 1, 1995; 2(4): 577 - 592. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
